Built from experience. Driven by purpose.
Star Medical Distribution UK Ltd is a specialist pharmaceutical wholesale and distribution company being developed in Glasgow, Scotland. Our purpose is to help create a stronger, more dependable supply chain for pharmaceutical products, controlled medicines and Cannabis-Based Products for Medicinal Use.
As the operating company within Star Life Sciences Group Limited, we are building a focused platform that combines pharmaceutical compliance, practical commercial understanding and genuine awareness of the challenges experienced by patients, pharmacies and healthcare providers.
Why Star Medical Distribution
The UK specialist medicines market has grown rapidly, yet patients and healthcare providers continue to experience inconsistent availability, variable pricing and interruptions to treatment. These are not abstract supply-chain issues: they directly affect confidence, clinical planning and patient wellbeing.
Star Medical Distribution is being built as a focused and responsive business designed to address those practical challenges through responsible sourcing, stronger partnerships, transparent communication and dependable execution.
Scotland-based. UK-focused.
Our East Kilbride operation is being developed around secure infrastructure, robust quality systems and long-term industry partnerships. The facility and Quality Management System are being designed to support Good Distribution Practice, controlled drug governance, product integrity, environmental control and full supply-chain traceability.
We are currently progressing the required UK pharmaceutical and controlled drug licensing and will commence regulated activities only once the appropriate approvals are in place. Until then, our focus remains on building the right systems, appointing experienced professionals and establishing responsible partnerships with manufacturers, pharmacies, clinics, logistics providers and specialist advisers.
Our long-term aim is straightforward: to become a dependable UK partner recognised for compliance, transparent communication, commercially realistic pricing and continuity of supply—while keeping patient safety at the centre of every decision.